Yemi adesokan biography of christopher

As a postdoctoral fellow at Harvard Medical School, he pioneered the development and implementation of the BioWeatherMap project, an initiative that collects real-time assays and uses them to track and limit viral outbreaks and antibiotic resistance in the developing world. An industry consultant with extensive experience in providing strategic advisory services to Fortune life-science companies, Yemi holds a BS in Biology from the University of Houston and a PhD in theoretical chemistry from the University of California, Irvine.

How would you describe your journey in the field of Biotechnology thus far? Exciting and challenging at the same time. My doctorate is in theoretical chemistry, so switching to genomics as a postdoctoral fellow at Harvard was frightening for a fleeting second. Biotechnology and genomics, in particular, has been a driver of the healthcare industry over the past decade, especially with the completion of the human genome project which has catalyzed the emergence of the field of personalized medicine.

I and the Pathogenica team feel very fortunate to be at the fore front of the genomics revolution. How do you feel about the honour, and why do you think you made the list? The successes of the TR35 innovators over the last few years show that the MIT Tech Review has a pretty solid track record of predicting emerging technologies and innovators. We are excited about the recognition, and we also realize this is no time to rest on our oars.

We are working as fast and as hard as ever before to commercialize this technology globally. What is the significance of your work to clinical diagnostics and how is it likely to impact the global healthcare industry? The DNA sequence of each individual or organism is unique, and is the most detailed signature for identification.

This year marks one decade since the completion of the Human Genome Project, a 3 billion dollar effort to sequence a human genome. The price continues to drop. We are applying this fast, inexpensive technology in a unique way to improve routine clinical diagnostics. The utility of the innovation in clinical practice lies in the the low error rate, thereby reducing the number of inaccurate diagnoses due to false positives or the emergence of drug resistance mutations undetected by current methods.

This reduces the occurrence of patient mortality death due to misdiagnosed infections. What do you expect from the Venture Leaders program, and how will it help you achieve your vision? We have already raised CHF 9 million in investor funding with a robust IP portfolio, strong underlying data, and a clear regulatory strategy. We are poised to raise a round of CHF 40 million to accelerate our human program and build a network of strategic partners.

We expect the Venture Leader program to provide a launchpad that boosts this effort. What is one thing not many people know about you? I played semi-pro basketball in Israel during graduate school. What is the one talent you wish you had? Playing the yemi adesokan biography of christopher better! I love songs by Bob Marley and wish I could play more of them.

What is your favorite podcast? Harvard Business Review IdeaCast. This weekly podcast features the leading thinkers in business and management and provides nuggets for practical and strategic management. Graeme has contributed book chapters and multiple peer reviewed publications in the fields of RNAi and human genetics, and invited presentations at international conferences.

Yemi adesokan biography of christopher

Graeme received a first class undergraduate degree from the University of Oxford, UK and completed his PhD training in the Department of Physiology at Oxford, studying the genetic epidemiology and molecular biology of human neurological disorders. Bill Cook Vice President Regulatory Affairs Bill Cook has over 30 years experience developing strategies and implementing business development initiatives with diagnostic companies.

In senior management positions at diaDexus, Inc. Bill has been an invited speaker at a variety of healthcare groups and acted as an industry consultant for clients including Cepheid, Cortex, Diagnocure, GlycoTech, and Genentech. Sabrina R. Sabrina trained at Columbia University Medical Center in New York for her Infectious Disease Fellowship where her research focused on fungal infections in transplant recipients, HIV and transplantation, and atypical mycobacterial infections.

He has more than 12 years of business development experience in the life sciences industry. He has been responsible for putting in place, in a number of companies the sales, marketing, and business development infrastructure. Most recently Mr. Prior to that Mr. Jessica Tonani Business Development Ms. Tonani is a co-founder of Delphi Bio.

Forgot your password? Password recovery. Recover your password. Get help. Heroes of Healthcare. See also. Ernest Izevbigie: The Grandmaster of Phytochemotheraphy. Please enter your comment! Please enter your name here. You have entered an incorrect email address! Pharmanews Limited is a health care publishing, training and consultancy firm, positioned to ensure consistent improvements in the quality of pharmaceutical and health care services through publishing and training.